Drugs / SLV334
last change Aug 2010 re-read 3 minutes ago

SLV334

Small molecule

Developed for
traumatic brain injury
Investigated by
Abbott Products · Quintiles, Inc.

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00735085 Apr 2009 → Aug 2010 traumatic brain injury Abbott Products Terminated No outcome recorded Stop: Business

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as SLV334 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00735085 ↗
Modality Small molecule — CHEMBL4297432 ↗
Route Intravenous “after Single and Multiple I.V. Doses of SLV334” NCT00735085 ↗